Table 1 Patients’ characteristics in the overall cohort and a compared between successful weaning after 1st extubation or not.

From: Weaning from mechanical ventilation during myasthenic crisis, a monocentric retrospective study

 

Overall

Successful weaning after 1st axtubation

Weaning failure after 1st extubation

p

Missing

n

126

108

18

  

Age (years old)

64 [42, 76]

66 [47, 77]

61 [39, 75]

0.286

0.0

Female

72 (56.5)

62 (56.6)

10 (55.6)

1.000

0.0

Body mass Index (Kg/m2)

25 [21, 28]

25 [22, 28]

21 [20, 24]

0.132

36.5

Medical history

 Pulmonary disease

18 (14.5)

16 (15.1)

2 (11.1)

0.935

1.6

 Cardiac Failure

14 (11.2)

13 (12.1)

1 (5.6)

0.677

0.8

Myasthenia gravis characteristics

 Delay from diagnosis to crisis (months)

9.7 [1.3, 59.4]

10.0 [1.6, 58.6]

3.8 [1.0, 72.6]

0.724

6.3

 Acetylcholine Receptor Antibody

110 (90.2)

95 (91.3)

15 (83.3)

0.532

3.2

 Muscle specific tyrosine kinase antibody

8 (6.6)

6 (5.8)

2 (11.1)

0.742

3.2

 Thymoma present

52 (42.6)

47 (45.2)

5 (27.8)

0.262

3.2

Long course treatment in non inaugural crisis

N = 75

N = 67

N = 7

  

 Thymectomy

29 (38.7)

27 (43.3)

2 (28.6)

0.449

0.0

 Corticoids

38 (51.4)

36 (53.7)

2 (28.6)

0.074

0.8

 Other immunosuppressive drugs

32 (43.2)

31 (46.3)

1 (14.3)

0.087

0.8

 Corticoids and another IS drug

23 (31.1)

23 (34.3)

0 (0)

0.15

 

 Cholinesterase inhibitors

71 (95.9)

64 (95.5)

11 (61.1)

0.175

2.4

Precipitating factor

94 (74.6)

86 (79.6)

8 (44.4)

0.004**

0.0

 Infection

51 (40.5)

50 (46.3)

1 (5.6)

0.003**

0.0

  Pneumonia

32 (35.6)

31 (37.8)

1 (12.5)

0.298

28.6

  Upper airways

12 (12.9)

12 (14.1)

0 (0.0)

0.557

26.2

  Other

11 (11.8)

11 (12.9)

0 (0.0)

0.609

26.2

 Iatrogenic cause

40 (31.7)

35 (32.4)

5 (27.8)

0.907

0.0

  Recent Surgery

22 (23.4)

19 (22.1)

3 (37.5)

0.584

25.4

  Treatment non-compliance

8 (8.6)

8 (9.4)

0 (0.0)

0.804

26.2

  Corticoids introduction

7 (7.4)

7 (8.1)

0 (0.0)

0.893

25.4

  Corticoids tapering

3 (3.2)

3 (3.5)

0 (0.0)

1.000

25.4

  Adverse event of another drug

6 (6.5)

4 (4.7)

2 (25.0)

0.139

26.2

 Other

15 (16.0)

13 (15.1)

2 (25.0)

0.822

25.4

Signs before mechanical ventilation

 MV as first sign

51 (40.8)

40 (37.4)

11 (61.1)

0.102

0.8

 Bulbar symptoms

100 (82.0)

84 (80.8)

16 (88.9)

0.620

3.2

  Swallowing disorder

78 (78.0)

67 (79.8)

11 (68.8)

0.519

0.0

  Macroscopic aspiration

41 (42.3)

36 (43.4)

5 (35.7)

0.807

3.0

 Oculomotor weakness

52 (44.1)

42 (41.6)

10 (58.8)

0.289

6.3

 Limb deficit

83 (69.7)

72 (71.3)

11 (61.1)

0.557

5.6

 Head lift deficit

68 (58.1)

56 (56.6)

12 (66.7)

0.590

7.1

MC treatment

 Feeding tube prior endotracheal intubation

27 (24.5)

22 (23.2)

5 (33.3)

0.597

12.7

 Corticosteroids increase

71 (59.7)

57 (56.4)

14 (77.8)

0.150

5.6

 IVIG

76 (71.7)

63 (70.8)

13 (76.5)

0.855

15.9

 PE

30 (28.6)

22 (25.0)

8 (47.1)

0.121

16.7

 IVIG and PE

16 (15.7)

11 (12.9)

5 (29.4)

0.180

19.0

 No PE nor IVIG

19 (17.4)

18 (19.6)

1 (5.9)

0.309

13.5

 NIV before intubation

14 (14.7)

12 (14.6)

2 (15.4)

1.000

24.6

General ICU severity scores

 Admission SOFA

4 [1, 5]

4 [1, 5]

3 [0, 5]

0.338

0.8

 SAPS II

45 [34, 56]

45 [34, 54]

46 [36, 56]

0.681

18.3

ICU adverse events

 Ventilator acquired pneumonia

32 (26.9)

24 (23.5)

8 (47.1)

0.084

5.6

 Septic shock

6 (5.0)

6 (5.8)

0 (0.0)

0.674

4.8

 Acute respiratory distress syndrome

5 (4.2)

5 (4.9)

0 (0.0)

0.785

4.8

 Other adverse events in ICU

27 (22.3)

23 (22.1)

4 (23.5)

1.000

4.0

Outcome

 Weaning duration

6 [3, 10]

6 [4, 10]

6 [3, 10]

0.921

7.9

 Mechanical ventilation duration

14[10,23]

14 [10, 23]

17 [10, 22]

0.683

5.6

 ICU length of stay (days)

22 [15, 35]

20 [14, 30]

36 [29, 50]

0.006**

11.9

 Hospital length of stay (days)

37 [27, 65]

34 [25, 59]

54 [40, 98]

0.004**

11.9

 Mortality

3 (2.5)

2 (2.0)

1 (5.6)

0.935

4.8

  1. The categorical variables are expressed as the absolute n (valid percentage); quantitative variables are expressed as the medians [interquartile ranges]; the distributions of categorical variables were compared using Fisher’s exact test and the quantitative variables were compared using Mann–Whitney-Wilcoxon U-test.*p < 0.5 ;**p <  < 0.01 ;***p < 0.001.
  2. IS, immunosuppressive; MV, mechanical ventilation; ICU, intensive care unit; SOFA, sequential organ failure assessment; SAPS II, Simplified Acute Physiology Score II.